» Articles » PMID: 3050691

Botulinum Toxin A-induced Protective Ptosis in Corneal Disease

Overview
Journal Ophthalmology
Publisher Elsevier
Specialty Ophthalmology
Date 1988 Apr 1
PMID 3050691
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Botulinum toxin A produces a temporary, flaccid ptosis when injected into the levator palpebrae superioris muscle. The resulting protective ptosis was used to aid healing in 21 cases of indolent ulceration, and, prophylactically, in 4 cases of neuroparalytic keratitis. Of the indolent ulcers, 90% healed completely. In all but one case, the cornea was covered completely by the lid and complete ptosis was produced in 75% of cases in an average of 3.6 days, lasting for 16 days on average before recovery began. Recovery of levator function was complete in 8.5 weeks on average. Superior rectus underaction was seen in 68% of cases but this recovered completely in all cases in an average of 6 weeks. Impression cytology showed a trend toward normal conjunctival morphology as healing progressed.

Citing Articles

Nonsurgical management of upper eyelid retraction in thyroid eye disease.

Young S, Kim Y, Woo K Taiwan J Ophthalmol. 2025; 14(4):548-553.

PMID: 39803393 PMC: 11717341. DOI: 10.4103/tjo.TJO-D-23-00043.


Chemical (Alkali) Burn-Induced Neurotrophic Keratitis Model in New Zealand Rabbit Investigated Using Medical Clinical Readouts and In Vivo Confocal Microscopy (IVCM).

Vohra M, Gour A, Rajput J, Sangwan B, Chauhan M, Goel K Cells. 2024; 13(5.

PMID: 38474343 PMC: 10931039. DOI: 10.3390/cells13050379.


The highest region of muscle spindle abundance should be the optimal target of botulinum toxin A injection to block muscle spasms in rats.

Yu J, Li Y, Yang L, Li Y, Zhang S, Yang S Front Neurol. 2023; 14:1061849.

PMID: 36908586 PMC: 9996071. DOI: 10.3389/fneur.2023.1061849.


Neurotization of the human cornea - A comprehensive review and an interim report.

Rathi A, Bothra N, Priyadarshini S, Achanta D, Fernandes M, Murthy S Indian J Ophthalmol. 2022; 70(6):1905-1917.

PMID: 35647955 PMC: 9359267. DOI: 10.4103/ijo.IJO_2030_21.


New Pharmacological Approaches for the Treatment of Neurotrophic Keratitis.

Koay S, Larkin D Front Pharmacol. 2022; 13:796854.

PMID: 35392574 PMC: 8981034. DOI: 10.3389/fphar.2022.796854.